In addition, serum GP73 levels have been shown to be more sensitive at the early stages of HCC (14), and Liu et al reported that GP73 may represent an effective serum marker for monitoring the progression of liver diseases (21). Here, GOLM1 is linked to hepatocellular carcinoma.